ABSTRACT In general, aquaculture wastes from traditional aquatic organism cultivation rapidly deteriorate the water quality of the surrounding ecosystems, endangering animals living in the area. The integrated multi-trophic aquaculture (IMTA) system is a bio-mitigation strategy to alleviate the adverse impacts caused by aquafarming pollutants on the environment and aquatic species. This study provides an overview of the IMTA system, explains the interactive processes among the different trophic levels, summarizes the major practices being followed around the temperate coastal waters with a field case study in Japan, and discusses the assessment of IMTA bio-mitigation efficiency through experimental greatly dependent on the customs and market values in the local IMTA practice. Bio-mitigation efficiency acquired in a land-based experiment exhibits its limitation in approach and conducts a comprehensive analysis on the possibility of applying numerical models to evaluate IMTA effectiveness. The selection of a suitable candidate organism is estimating that in the same or different culture conditions with various biomasses of extractive species. However, in open water experiments, it is difficult to evaluate the bio-mitigation effect of extractive species because the initial biomass ratio (IBR) of the extractive to target species is too small. Alternatively, the possibility of applying existing numerical models to assess IMTA is relatively low. In conclusion, an optimally designed large-scale IMTA experiment is required, in which the IBR of the extractive to target species is adequately considered, and a full-scale IMTA model should be further improved with a database of individual-based submodels for IMTA candidate organisms.

ABSTRACT Objectives: Our study aimed to investigate the associations of glucose tolerance status with insulin-like growth factor-I (IGF-I) and other clinical laboratory parameters of acromegalic patients before and after the patients underwent transsphenoidal adenomectomy (TSA) by conducting a single-center, retrospective study. Subjects and methods: A total of 218 patients with acromegaly who had undergone TSA as the first treatment were retrospectively analyzed. Serum IGF-I, growth hormone (GH) and glucose levels were measured before and after surgery. Results: The follow-up levels for random GH, GH nadir, and the percentage of the upper limit of normal IGF-I (%ULN IGF-I) were decreased significantly. The percentages of normal (39.0%), early carbohydrate metabolism disorders (33.0%) and diabetes mellitus (28.0%) changed to 70.2%, 16.5% and 13.3%, respectively, after TSA. %ULN IGF-I at baseline was higher in the diabetes mellitus (DM) group than in the normal glucose tolerance group and impaired glucose tolerance (IGT) /impaired fasting glucose (IFG) groups before TSA, and the DM group exhibited a greater reduction in %ULN IGF-I value after surgery. The follow-up %ULN IGF-I value after surgery was significantly lower in the improved group, and Pearson's correlation analysis revealed that the reductions in %ULN IGF-I corresponded with the reductions in glucose level. Conclusion: This study examined the largest reported sample with complete preoperative and follow-up data. The results suggest that the age- and sex-adjusted IGF-I level, which reflects altered glucose metabolism, and the change of it are associated with improved glucose tolerance in acromegalic patients both before and after TSA.